SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Hussain, I.,Powell, D.,Howlett, D. R.,Tew, D. G.,Meek, T. D. et al. (1999)Identification of a novel aspartic protease (Asp 2) as beta-secretase.Mol. Cell. Neurosci. 14,419427.
  • 2
    Sinha, S.,Anderson, J. P.,Barbour, R.,Basi, G. S.,Caccavello, R. et al. (1999)Purification and cloning of amyloid precursor protein beta-secretase from human brain.Nature 402,537540.
  • 3
    Vassar, R.,Bennett, B. D.,Babu-Khan, S.,Kahn, S.,Mendiaz, E. A. et al. (1999)Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.Science 286,735741.
  • 4
    Yan, R.,Bienkowski, M. J.,Shuck, M. E.,Miao, H.,Tory, M. C. et al. (1999)Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.Nature 402,533537.
  • 5
    Lin, X.,Koelsch, G.,Wu, S.,Downs, D.,Dashti, A. et al. (2000)Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein.Proc. Natl. Acad. Sci. USA. 97,14561460.
  • 6
    Hong, L.,Koelsch, G.,Lin, X.,Wu, S.,Terzyan, S et al. (2000)Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor.Science 290,150153.
  • 7
    Evin, G.,Lessene, G., and Wilkins, S. (2011)BACE inhibitors as potential drugs for the treatment of Alzheimer's disease: focus on bioactivity.Recent Pat. CNS Drug Discov. 6,91106.
  • 8
    Creemers, J. W.,Ines Dominguez, D.,Plets, E.,Serneels, L.,Taylor, N. A. et al. (2001)Processing of beta-secretase by furin and other members of the proprotein convertase family.J. Biol. Chem. 276,42114217.
  • 9
    Haniu, M.,Denis, P.,Young, Y.,Mendiaz, E. A.,Fuller, J. et al. (2000)Characterization of Alzheimer's beta-secretase protein BACE. A pepsin family member with unusual properties.J. Biol. Chem. 275,2109921106.
  • 10
    Charlwood, J.,Dingwall, C.,Matico, R.,Hussain, I.,Johanson, K. et al. (2001)Characterization of the glycosylation profiles of Alzheimer's beta-secretase protein Asp-2 expressed in a variety of cell lines.J. Biol. Chem. 276,1673916748.
  • 11
    Capell, A.,Steiner, H.,Willem, M.,Kaiser, H.,Meyer, C. et al. (2000)Maturation and pro-peptide cleavage of beta-secretase.J. Biol. Chem. 275,3084930854.
  • 12
    Benjannet, S.,Elagoz, A.,Wickham, L.,Mamarbachi, M.,Munzer, J. S. et al. (2001)Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production.J. Biol. Chem. 276,1087910887.
  • 13
    Pinnix, I.,Council, J. E.,Roseberry, B.,Onstead, L.,Mallender, W. et al. (2001)Convertases other than furin cleave beta-secretase to its mature form.FASEB J. 15,18101812.
  • 14
    Holsinger, R. M.,McLean, C. A.,Beyreuther, K.,Masters, C. L., and Evin, G. (2002)Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease.Ann. Neurol. 51,783786.
  • 15
    Fukumoto, H.,Cheung, B. S.,Hyman, B. T., and Irizarry, MC. (2002)Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease.Arch. Neurol. 59,13811389.
  • 16
    Yang, L. B.,Lindholm, K.,Yan, R.,Citron, M.,Xia, W. et al. (2003)Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease.Nat. Med. 9,34.
  • 17
    Hyman, B. T.,Phelps, C. H.,Beach, T. G.,Bigio, E. H.,Cairns, N. J. et al. (2012)National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.Alzheimers Dement. 8,113.
  • 18
    Huang, X.,Moir, R. D.,Tanzi, R. E.,Bush, A. I., and Rogers, J. T. (2004)Redox-active metals, oxidative stress, and Alzheimer's disease pathology.Ann. N Y Acad. Sci. 1012,153163.
  • 19
    Cai, Z.,Zhao, B., and Ratka, A. (2011)Oxidative stress and β-amyloid protein in Alzheimer's disease.Neuromol. Med. 13,223250.
  • 20
    Tamagno, E.,Bardini, P.,Obbili, A.,Vitali, A.,Borghi, R. et al. (2002)Oxidative stress increases expression and activity of BACE in NT2 neurons.Neurobiol. Dis. 10,279288.
  • 21
    Tamagno, E.,Guglielmotto, M.,Bardini, P.,Santoro, G.,Davit, A. et al. (2003)Dehydroepiandrosterone reduces expression and activity of BACE in NT2 neurons exposed to oxidative stress.Neurobiol. Dis. 14,291301.
  • 22
    Tamagno, E.,Parola, M.,Bardini, P.,Piccini, A.,Borghi, R. et al. (2005)Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways.J. Neurochem. 92,628636.
  • 23
    Tamagno, E.,Guglielmotto, M.,Aragno, M.,Borghi, R.,Autelli, R. et al. (2008)Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein.J. Neurochem. 104,683695.
  • 24
    Jo, D. G.,Arumugam, T. V.,Woo, H. N.,Park, J. S.,Tang, S. C. et al. (2010)Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimer's disease.Neurobiol. Aging 31,917925.
  • 25
    Verri, M.,Pastoris, O.,Dossena, M.,Aquilani, R.,Guerriero, F. et al. (2012)Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimers disease.Int. J. Immunopathol. Pharmacol. 25,345353.
  • 26
    Sastre, M.,Dewachter, I.,Rossner, S.,Bogdanovic, N.,Rosen, E. et al. (2006)Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma.Proc. Natl. Acad. Sci. USA. 103,443448.
  • 27
    Giliberto, L.,Borghi, R.,Piccini, A.,Mangerini, R.,Sorbi, S. et al. (2009)Mutant presenilin 1 increases the expression and activity of BACE1.J. Biol. Chem. 284,90279038.
  • 28
    Guglielmotto, M.,Monteleone, D.,Giliberto, L.,Fornaro, M.,Borghi, R. et al. (2011).Amyloid-β42 activates the expression of BACE1 through the JNK pathway.J. Alzheimers Dis. 27,871883.
  • 29
    Piccini, A.,Zanusso, G.,Borghi, R.,Noviello, C.,Monaco, S. et al. (2007)Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype.Arch. Neurol. 64,738745.
  • 30
    Assini, A.,Terreni, L.,Borghi, R.,Giliberto, L.,Piccini, A. et al. (2003)Pure spastic paraparesis associated with a novel presenilin 1 R278K mutation.Neurology 60,150151.
  • 31
    Takao, M.,Ghetti, B.,Murrell, J. R.,Unverzagt, F. W.,Giaccone, G. et al. (2001)Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures.J. Neuropathol. Exp. Neurol. 60,11371152.
  • 32
    Liu, K.,Doms, R. W., and Lee, V. M. (2002)Glu11 site cleavage and N-terminally truncated A beta production upon BACE overexpression.Biochemistry 41,31283136.
  • 33
    Schilling, S.,Lauber, T.,Schaupp, M.,Manhart, S.,Scheel, E. et al. (2006)On the seeding and oligomerization of pGlu-amyloid peptides (in vitro).Biochemistry 45,1239312399.
  • 34
    Piccini, A.,Russo, C.,Ghiozzi, A.,Relini, A.,Vitali, A. et al. (2005)Beta-amyloid is different in normal aging and in Alzheimer disease.J. Biol. Chem. 280,3418634192.
  • 35
    Meyer-Luehmann, M.,Coomaraswamy, J.,Bolmont, T.,Kaeser, S.,Schaefer, C. et al. (2006)Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and Host.Science 313,17811784.
  • 36
    Tabaton, M. and Gambetti, P. (2006)Soluble amyloid-beta in the brain: the scarlet pimpernel.J. Alzheimers Dis. 9,127132.
  • 37
    Petkova, A. T.,Leapman, R. D.,Guo, Z.,Yau, W. M., and Mattson, M. P. (2005)Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils.Science 307,262265.
  • 38
    Sambamurti, K.,Kinsey, R.,Maloney, B.,Ge, Y. W., and Lahiri, D. K. (2004)Gene structure and organization of the human beta-secretase (BACE) promoter.FASEB J. 18,10341036.
  • 39
    Christensen, M. A.,Zhou, W.,Qing, H.,Lehman, A.,Philipsen, S. et al. (2004)Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1.Mol. Cell. Biol. 24,865874.
  • 40
    Basha, M. R.,Wei, W.,Bakheet, S. A.,Benitez, N.,Siddiqi, H. K. et al. (2005)The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain.J. Neurosci. 25,823829.
  • 41
    Adwan, L. I.,Basha, R.,Abdelrahim, M.,Subaiea, G. M., and Zawia, N. H. (2011)Tolfenamic acid interrupts the de novo synthesis of the β-amyloid precursor protein and lowers amyloid beta via a transcriptional pathway.Curr. Alzheimer Res. 8,385392.
  • 42
    Chu, J.,Zhuo, J. M., and Praticò, D. (2012)Transcriptional regulation of β-secretase-1 by 12/15-lipoxygenase results in enhanced amyloidogenesis and cognitive impairments.Ann. Neurol. 71,5767.
  • 43
    Camandola, S.,Poli, G., and Mattson, M. P. (2000)The lipid peroxidation product 4-hydroxy-2,3-nonenal inhibits constitutive and inducible activity of nuclear factor kappa B in neurons.Brain Res. Mol. Brain Res. 85,5360.
  • 44
    Mattson, M. P. (2004)Pathways towards and away from Alzheimer's disease.Nature 430,631639.
  • 45
    Kaltschmidt, B.,Uherek, M.,Wellmann, H.,Volk, B., and Kaltschmidt, C. (1999)Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis.Proc. Natl. Acad. Sci. USA 96,94099414.
  • 46
    Kaltschmidt, B.,Uherek, M.,Volk, B.,Baeuerle, P. A., and Kaltschmidt, C. (1997)Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease.Proc. Natl. Acad. Sci. USA 94,26422647.
  • 47
    Buggia-Prevot, V.,Sevalle, J.,Rossner, S., and Checler, F. (2008)NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42.J. Biol. Chem. 283,1003710047.
  • 48
    Guglielmotto, M.,Aragno, M.,Tamagno, E.,Vercellinatto, I.,Visentin, S. et al. (2012)AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation.Neurobiol. Aging 33,196.e13196.e1327.
  • 49
    Granic, I.,Dolga, A. M.,Nijholt, I. M.,van Dijk, G., and Eisel, U. L. (2009)Inflammation and NF-kappaB in Alzheimer's disease and diabetes.J. Alzheimers Dis. 16,809821.
  • 50
    Kuang, X.,Scofield, V. L.,Yan, M.,Stoica, G.,Liu, N. et al. (2009)Attenuation of oxidative stress, inflammation and apoptosis by minocycline prevents retrovirus-induced neurodegeneration in mice.Brain Res. 1286,174184.
  • 51
    Cai, Z.,Zhao, Y.,Yao, S., and Bin Zhao, B. (2011)Increases in β-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-κB pathway activation.Pharmacol. Rep. 63,381391.
  • 52
    Paris, D.,Beaulieu-Abdelahad, D.,Bachmeier, C.,Reed, J.,Ait-Ghezala, G. et al. (2011)Anatabine lowers Alzheimer's Aβ production in vitro and in vivo.Eur. J. Pharmacol. 670,384391.
  • 53
    Yi, H.,Lee, S. J.,Lee, J.,Myung, C. S.,Park, W. K. et al. (2011)Sphingosylphosphorylcholine attenuated β-amyloid production by reducing BACE1 expression and catalysis in PC12 cells.Neurochem. Res. 36,20832090.
  • 54
    Chami, L.,Buggia-Prévot, V.,Duplan, E.,Delprete, D.,Chami, M. et al. (2012)Nuclear factor-κB regulates βAPP and β- and γ-secretases differently at physiological and supraphysiological Aβ concentrations.J. Biol. Chem. 287,2457324584.
  • 55
    Tamagno, E.,Guglielmotto, M.,Giliberto, L.,Vitali, A.,Borghi, R. et al. (2009)JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1.Neurobiol. Aging 30,15631573.
  • 56
    Chen, Y.,Zhou, K.,Wang, R.,Liu, Y.,Kwak, Y. D. et al. (2009)Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription.Proc. Natl. Acad. Sci. USA 106,3907.
  • 57
    Grammas, P.,Sanchez, A.,Tripathy, D.,Luo, E., and Martinez, J. (2011)Vascular signaling abnormalities in Alzheimer disease.Cleve Clin. J. Med. 78,S50S53.
  • 58
    de la Torre, J. C. and Stefano, G. B. (2000)Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide.Brain Res. Brain Res. Rev. 34,119136.
  • 59
    Sun, X.,He, G.,Qing, H.,Zhou, W.,Dobie, F. et al. (2006)Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression.Proc. Natl. Acad. Sci. USA 103,1872718732.
  • 60
    Zhang, X.,Zhou, K.,Wang, R.,Cui, J.,Lipton, S. A. et al. (2007)Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation.J. Biol. Chem. 282,1087310880.
  • 61
    Guglielmotto, M.,Aragno, M.,Autelli, R.,Giliberto, L.,Novo, E. et al. (2009)The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha.J. Neurochem. 108,10451056.
  • 62
    Bulbarelli, A.,Lonati, E.,Brambilla, A.,Orlando, A.,Cazzaniga, E. et al. (2012)Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation.Mol. Cell Neurosci. 49,415422.
  • 63
    Li, Q. Y.,Wang, H. M.,Wang, Z. Q.,Ma, J. F.,Ding, J. Q. et al. (2010)Salidroside attenuates hypoxia-induced abnormal processing of amyloid precursor protein by decreasing BACE1 expression in SH-SY5Y cells.Neurosci. Lett. 481,154158.
  • 64
    Zhu, X.,Raina, A. K.,Lee, H. G.,Chao, M.,Nunomura, A. et al. (2003)Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways.Antioxid. Redox Signal 5,571576.
  • 65
    Lagalwar, S.,Guillozet-Bongaarts, A. L.,Berry, R. W., and Binder, L. I. (2006)Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease.J. Neuropathol. Exp. Neurol. 65,455464.
  • 66
    Thakur, A.,Wang, X.,Siedlak, S. L.,Perry, G.,Smith, M. A. et al. (2007)c-Jun phosphorylation in Alzheimer disease.J. Neurosci. Res. 85,166816673.
  • 67
    Pugazhenthi, S.,Phansalkar, K.,Audesirk, G.,West, A., and Cabell, L. (2006)Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal.Free Radic. Biol. Med. 40,2134.
  • 68
    Kanzawa, T.,Iwado, E.,Aoki, H.,Iwamaru, A.,Hollingsworth, E. F. et al. (2006)Ionizing radiation induces apoptosis and inhibits neuronal differentiation in rat neural stem cells via the c-Jun NH2-terminal kinase (JNK) pathway.Oncogene 25,36383648.
  • 69
    Zhang, Q. G.,Wu, D. N.,Han, D., and Zhang, G. Y. (2007)Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury.FEBS Lett. 581,495505.
  • 70
    Martisova, E.,Solas, M.,Gereñu, G.,Milagro, F. I.,Campion, J. et al. (2012)Mechanisms involved in BACE upregulation associated to stress.Curr. Alzheimer Res. Epub ahead of print.
  • 71
    Puig, B.,Gómez-Isla, T.,Ribé, E.,Cuadrado, M.,Torrejón-Escribano, B. et al. (2004)Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice.Neuropathol. Appl. Neurobiol. 30,491502.
  • 72
    Pearson, A. G.,Byrne, U. T.,MacGibbon, G. A.,Faull, R. L., and Dragunow, M. (2006)Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains.Neurosci. Lett. 398,246250.
  • 73
    Tatebayashi, Y.,Planel, E.,Chui, D. H.,Sato, S.,Miyasaka, T. et al. (2006)c-jun N-terminal kinase hyperphosphorylates R406W tau at the PHF-1 site during mitosis.FASEB J. 20,762764.
  • 74
    Lauren, J.,Gimbel, D. A.,Nygaard, H. B.,Gilbert, J. W., and Strittmatter, S. M. (2009)Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.Nature 457,112811132.
  • 75
    Bu, G.,Cam, J., and Zerbinatti, C. (2006)LRP in amyloid-beta production and metabolism.Ann. N Y Acad. Sci. 1086,3553.
  • 76
    De Pietri Tonelli, D.,Mihailovich, M.,Di Cesare, A.,Codazzi, F., and Grohovaz, F. (2004)Translational regulation of BACE-1 expression in neuronal and non-neuronal cells.Nucleic. Acids Res. 32,18081817.
  • 77
    Wong, P. C. (2008)Translational control of BACE1 may go awry in Alzheimer's disease.Neuron 60,941943.
  • 78
    Lammich, S.,Schöbel, S.,Zimmer, A. K.,Lichtenthaler, S. F., and Haass, C. (2004)Expression of the Alzheimer protease BACE1 is suppressed via its 5′-untranslated region.EMBO Rep. 5,620625.
  • 79
    O'Connor, T.,Sadleir, K. R.,Maus, E.,Velliquette, R. A.,Zhao, J. et al. (2008)Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis.Neuron 60,9881009.
  • 80
    Tesco, G.,Koh, Y. H.,Kang, E. L.,Cameron, A. N., and Das, S. (2007)Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity.Neuron 54,721737.
  • 81
    Koh, Y. H.,von Arnim, C. A.,Hyman, B. T.,Tanzi, R. E., and Tesco, G. (2005)BACE is degraded via the lysosomal pathway.J. Biol. Chem. 280,3249932504.
  • 82
    He, X.,Li, F.,Chang, W. P., and Tang, J. (2005)GGA proteins mediate the recycling pathway of memapsin 2 (BACE).J. Biol. Chem. 280,1169611703.
  • 83
    He, X.,Zhu, G.,Koelsch, G.,Rodgers, K. K.,Zhang, X. C. et al. (2003)Biochemical and structural characterization of the interaction of memapsin 2 (beta-secretase) cytosolic domain with the VHS domain of GGA proteins.Biochemistry 42,1217412180.
  • 84
    Wahle, T.,Prager, K.,Raffler, N.,Haass, C.,Famulok, M. et al. (2005)GGA proteins regulate retrograde transport of BACE1 from endosomes to the trans-Golgi network.Mol. Cell Neurosci. 29,453461.
  • 85
    Kang, E. L.,Cameron, A. N.,Piazza, F.,Walker, K. R., and Tesco, G. (2010)Ubiquitin regulates GGA3-mediated degradation of BACE1.J. Biol. Chem. 285,2410824119.
  • 86
    Puertollano, R. and Bonifacino, J. S. (2004)Interactions of GGA3 with the ubiquitin sorting machinery.Nat. Cell Biol. 6,244251.
  • 87
    Deng, Y.,Guo, Y.,Watson, H.,Au, W. C.,Shakoury-Elizeh, M. et al. (2009)Gga2 mediates sequential ubiquitin-independent and ubiquitin-dependent steps in the trafficking of ARN1 from the trans-Golgi network to the vacuole.J. Biol. Chem. 284,2383023841.
  • 88
    Wildasin, K. (2004)Role of reticulon proteins in Alzheimer's disease.Lancet Neurol. 3,576.
  • 89
    Masliah, E.,Xie, F.,Dayan, S.,Rockenstein, E.,Mante, M. et al. (2010)Genetic deletion of Nogo/Rtn4 ameliorates behavioral and neuropathological outcomes in amyloid precursor protein transgenic mice.Neuroscience 169,488494.
  • 90
    Araki, W.,Oda, A.,Motoki, K.,Hattori, K.,Itoh, M. et al. (2012)Reduction of β-amyloid accumulation by reticulon 3 in transgenic mice.Curr. Alzheimer Res. Epub ahead of print.
  • 91
    Faghihi, M. A.,Modarresi, F.,Khalil, A.M.,Wood, D. E.,Sahagan, B. G. et al. (2008)Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase.Nat. Med. 14,723730.
  • 92
    Mowrer, K. R. and Wolfe, M. S. (2008)Promotion of BACE1 mRNA alternative splicing reduces amyloid beta-peptide production.J. Biol. Chem. 283,1869418701.
  • 93
    Kamenetz, F.,Tomita, T.,Hsieh, H.,Seabrook, G.,Borchelt, D. et al. (2003)APP processing and synaptic function.Neuron 37,925937.
  • 94
    De Taboada, L.,Yu, J.,El-Amouri, S.,Gattoni-Celli, S.,Richieri, S. et al. (2011)Transcranial laser therapy attenuates amyloid-β peptide neuropathology in amyloid-β protein precursor transgenic mice.J. Alzheimers Dis. 23,521535.
  • 95
    Gatta, V.,Drago, D.,Fincati, K.,Valenti, M. T.,Dalle Carbonare, L. et al. (2011)Microarray analysis on human neuroblastoma cells exposed to aluminum, β(1-42)-amyloid or the β(1-42)-amyloid aluminum complex.PLoS One 6,e15965.
  • 96
    Piccini, A.,Borghi, R.,Guglielmotto, M.,Tamagno, E.,Cirmena, G. et al. (2012)β-Amyloid 1-42 induces physiological transcriptional regulation of BACE1.J. Neurochem. 122,10231031.
  • 97
    Mira, E. and Castano, J. G. (1989)Insulin short-term control of rat liver alpha 2-microglobulin gene transcription.J. Biol. Chem. 264,1820918212.
  • 98
    Guglielmotto, M.,Monteleone, D.,Boido, M.,Piras, A.,Giliberto, L. et al. (2012)Aβ 1-42-mediated down-regulation of Uch-L1 is dependent on NF-κB activation and impaired BACE1 lysosomal degradation.Aging Cell. 11, 834–844.
  • 99
    Wilkinson, K. D.,Lee, K. M.,Deshpande, S.,Duerksen-Hughes, P.,Boss, J. M. et al. (1989)The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase.Science 246,670673.
  • 100
    Gong, B. and Leznik, E. (2007)The role of ubiquitin C-terminal hyrolase L1 in neurodegenerative disorders.Drug News Perspect. 20,365370.
  • 101
    Pasinetti, G. M. (2001)Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia.J. Neurosci. Res. 65,471476.
  • 102
    Choi, J.,Levey, A. I.,Weintraub, S. T.,Rees, H. D.,Gearing, M. et al. (2004)Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.J. Biol. Chem. 279,1325613264.
  • 103
    Ichihara, N.,Wu, J.,Chui, D. H.,Yamazaki, K.,Wakabayashi, T. et al. (1995)Axonal degeneration promotes abnormal accumulation of amyloid beta-protein in ascending gracile tract of gracile axonal dystrophy (GAD) mouse.Brain Res. 695,173178.
  • 104
    Gong, B.,Cao, Z.,Zheng, P.,Vitolo, O. V.,Liu, S. et al. (2006)Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory.Cell 126,775788.
  • 105
    Trinchese, F.,Liu, S.,Battaglia, F.,Walter, S.,Mathews, P. M. et al. (2004)Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.Ann. Neurol. 55,801814.
  • 106
    Tong, L.,Thornton, P. L.,Balazs, R., and Cotman, C. W. (2001)Beta-amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival is not compromised.J. Biol. Chem. 276,1730117306.
  • 107
    Zhang, M.,Deng, Y.,Luo, Y.,Zhang, S.,Zou, H. et al. (2012)Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1.J. Neurochem. 120,11291138.
  • 108
    Wang, R.,Zhang, M.,Zhou, W.,Ly, P. T.,Cai, F. et al. (2011)NF-κB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression.J. Neurochem. 116,11601170.
  • 109
    Cuervo, A. M. (2004)Autophagy: in sickness and in health.Trends Cell. Biol. 14,7077.
  • 110
    Lee, J. A. (2009)Autophagy in neurodegeneration: two sides of the same coin.BMB Rep. 42,324330.
  • 111
    Cardoso, S. M.,Pereira, C. F.,Moreira, P. I.,Arduino, D. M.,Esteves, A. R. et al. (2010)Mitochondrial control of autophagic lysosomal pathway in Alzheimer's disease.Exp. Neurol. 223,294298.
  • 112
    Yang, D. S.,Stavrides, P.,Mohan, P. S.,Kaushik, S.,Kumar, A. et al. (2011)Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis.Autophagy 7,788789.
  • 113
    Nixon, R. A. and Cataldo, A. M. (2006)Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease.J. Alzheimers Dis. 9,277289.